Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 766

1.

The management of polycystic liver disease by tolvaptan.

Takenaka T, Miura S, Kitajima M.

Clin Mol Hepatol. 2019 Jun 13. doi: 10.3350/cmh.2019.0026. [Epub ahead of print] No abstract available.

2.

An easy and novel method for safer brachytherapy: real-time fluoroscopic verification of high-dose-rate 192Ir source position using a flat-panel detector.

Nose T, Masui K, Takenaka T, Yamazaki H, Nakata K, Otani Y, Kumita S.

J Radiat Res. 2019 May 1;60(3):412-415. doi: 10.1093/jrr/rrz013.

3.

TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models.

Yoshimura C, Muraoka H, Ochiiwa H, Tsuji S, Hashimoto A, Kazuno H, Nakagawa F, Komiya Y, Suzuki S, Takenaka T, Kumazaki M, Fujita N, Mizutani T, Ohkubo S.

Mol Cancer Ther. 2019 Jul;18(7):1205-1216. doi: 10.1158/1535-7163.MCT-18-0644. Epub 2019 May 15.

PMID:
31092565
4.

Prognosis of Early-stage Part-solid and Pure-solid Lung Adenocarcinomas.

Kinoshita F, Toyokawa G, Matsubara T, Kozuma Y, Haratake N, Takamori S, Akamine T, Hirai F, Takenaka T, Tagawa T, Maehara Y.

Anticancer Res. 2019 May;39(5):2665-2670. doi: 10.21873/anticanres.13391.

PMID:
31092466
5.

Association between Chronic Pain and Physical Frailty in Community-Dwelling Older Adults.

Nakai Y, Makizako H, Kiyama R, Tomioka K, Taniguchi Y, Kubozono T, Takenaka T, Ohishi M.

Int J Environ Res Public Health. 2019 Apr 13;16(8). pii: E1330. doi: 10.3390/ijerph16081330.

6.

The Association between Osteoporosis and Grip Strength and Skeletal Muscle Mass in Community-Dwelling Older Women.

Taniguchi Y, Makizako H, Kiyama R, Tomioka K, Nakai Y, Kubozono T, Takenaka T, Ohishi M.

Int J Environ Res Public Health. 2019 Apr 6;16(7). pii: E1228. doi: 10.3390/ijerph16071228.

7.

Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy.

Kim WS, Kim HS, Shin J, Park JC, Yoo HW, Takenaka T, Tei C.

J Korean Med Sci. 2019 Feb 15;34(7):e63. doi: 10.3346/jkms.2019.34.e63. eCollection 2019 Feb 25.

8.

Primary pulmonary collision tumor comprising squamous cell carcinoma and mucosa-associated lymphoid tissue lymphoma.

Yamasaki M, Takenaka T, Matsumoto N, Asaoku H, Taniwaki M, Hattori N.

Lung Cancer. 2019 Mar;129:107-109. doi: 10.1016/j.lungcan.2018.12.019. Epub 2018 Dec 18. No abstract available.

PMID:
30591232
9.

Associations of social frailty with loss of muscle mass and muscle weakness among community-dwelling older adults.

Makizako H, Kubozono T, Kiyama R, Takenaka T, Kuwahata S, Tabira T, Kanoya T, Horinouchi K, Shimada H, Ohishi M.

Geriatr Gerontol Int. 2019 Jan;19(1):76-80. doi: 10.1111/ggi.13571. Epub 2018 Dec 21.

PMID:
30575241
10.

VEGF-C and Mortality in Patients With Suspected or Known Coronary Artery Disease.

Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagami S, Yonezawa K, Shimizu M, Funada J, Takenaka T, Morita Y, Nakamura T, Fujimoto K, Matsubara H, Kato T, Unoki T, Takagi D, Ura S, Wada K, Iguchi M, Masunaga N, Ishii M, Yamakage H, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K; ANOX Study Investigators.

J Am Heart Assoc. 2018 Nov 6;7(21):e010355. doi: 10.1161/JAHA.118.010355.

11.

Acute median arcuate ligament syndrome after pancreaticoduodenectomy.

Imai D, Maeda T, Wang H, Ohmine T, Edahiro K, Edagawa M, Takenaka T, Yamaguchi S, Konishi K, Tsutsui S, Matsuda H.

Surg Case Rep. 2018 Nov 26;4(1):137. doi: 10.1186/s40792-018-0545-x.

12.

Inferred systolic blood pressure levels to switch from lifestyle modifications to antihypertensive medications: a success-rate oriented simulation.

Ohno Y, Takenaka T, Suzuki H.

Clin Exp Hypertens. 2018 Nov 22:1-7. doi: 10.1080/10641963.2018.1545848. [Epub ahead of print]

PMID:
30466333
13.

Klotho Ameliorates Medullary Fibrosis and Pressure Natriuresis in Hypertensive Rat Kidneys.

Takenaka T, Inoue T, Miyazaki T, Kobori H, Nishiyama A, Ishii N, Hayashi M, Suzuki H.

Hypertension. 2018 Nov;72(5):1151-1159. doi: 10.1161/HYPERTENSIONAHA.118.11176.

14.

Correlation Between Dosimetric Parameters and Acute Dermatitis of Post-operative Radiotherapy in Breast Cancer Patients.

Takenaka T, Yamazaki H, Suzuki G, Aibe N, Masui K, Shimizu D, Nishimura T, Nakashima A, Ogata T, Matsushita K, Yoshida K, Yamada K.

In Vivo. 2018 Nov-Dec;32(6):1499-1504. doi: 10.21873/invivo.11406.

15.

Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes.

Takenaka T, Kobori H, Miyazaki T, Suzuki H, Nishiyama A, Ishii N, Yamashita M, Hayashi M.

Acta Physiol (Oxf). 2019 Feb;225(2):e13190. doi: 10.1111/apha.13190. Epub 2018 Oct 16.

16.

Comparison of radiation dermatitis between hypofractionated and conventionally fractionated postoperative radiotherapy: objective, longitudinal assessment of skin color.

Yamazaki H, Takenaka T, Aibe N, Suzuki G, Yoshida K, Nakamura S, Masui K, Kimoto T, Sasaki N, Nishimura T, Nakashima A, Goto M, Yamada K.

Sci Rep. 2018 Aug 17;8(1):12306. doi: 10.1038/s41598-018-30710-4.

17.

Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control.

Suzuki G, Yamazaki H, Aibe N, Masui K, Shimizu D, Kimoto T, Nishimura T, Nakashima A, Takenaka T, Dohi O, Ishikawa T, Yamada K.

Cancers (Basel). 2018 Aug 3;10(8). pii: E259. doi: 10.3390/cancers10080259.

18.

High central blood pressure is associated with incident cardiovascular events in treated hypertensives: the ABC-J II Study.

Eguchi K, Miyashita H, Takenaka T, Tabara Y, Tomiyama H, Dohi Y, Hashimoto J, Ohkubo T, Ohta Y, Hirooka Y, Kohara K, Ito S, Kawano Y, Sunagawa K, Suzuki H, Imai Y, Kario K, Takazawa K, Yamashina A, Shimada K; ABC-J II Investigator Group.

Hypertens Res. 2018 Nov;41(11):947-956. doi: 10.1038/s41440-018-0075-8. Epub 2018 Aug 2.

PMID:
30072732
19.

Freehand Technique of an Electromagnetic Navigation System Emitter to Avoid Interference Caused by Metal Neurosurgical Instruments.

Takenaka T, Toyota S, Kuroda H, Kobayashi M, Kumagai T, Mori K, Taki T.

World Neurosurg. 2018 Oct;118:143-147. doi: 10.1016/j.wneu.2018.07.071. Epub 2018 Jul 17.

PMID:
30026149
20.

Pulmonary Tumor Thrombotic Microangiopathy Induced by Prostate Cancer.

Katayama S, Takenaka T, Nakamura A, Sako S, Bessho A, Ohara N.

Acta Med Okayama. 2018 Jun;72(3):309-313. doi: 10.18926/AMO/56078.

21.

Prognostic ability of new T1 descriptors in the tumour, node and metastasis classification of surgically treated non-small-cell lung cancer.

Takenaka T, Yamazaki K, Miura N, Takeo S.

Interact Cardiovasc Thorac Surg. 2018 Nov 1;27(5):714-719. doi: 10.1093/icvts/ivy164.

PMID:
29788086
22.

Immune checkpoint therapy in proteinuric kidney disease.

Takenaka T, Kawai Y, Amano T.

Eur J Cancer. 2018 May;95:120-122. doi: 10.1016/j.ejca.2018.02.007. Epub 2018 Mar 9. No abstract available.

PMID:
29530540
23.

Elevated pulse amplification in hypertensive patients with advanced kidney disease.

Takenaka T, Suzuki H, Eguchi K, Miyashita H, Shimada K; ABC-J II study group.

Hypertens Res. 2018 Apr;41(4):299-307. doi: 10.1038/s41440-017-0010-4. Epub 2018 Jan 30.

PMID:
29382899
24.

How to manage patients with subcentimeter non-small cell lung cancer?

Takenaka T.

J Thorac Dis. 2017 Dec;9(12):4860-4862. doi: 10.21037/jtd.2017.11.24. No abstract available.

25.

Oxidative stress increases megalin expression in the renal proximal tubules during the normoalbuminuric stage of diabetes mellitus.

Kurosaki Y, Imoto A, Kawakami F, Yokoba M, Takenaka T, Ichikawa T, Katagiri M, Ishii N.

Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F462-F470. doi: 10.1152/ajprenal.00108.2017. Epub 2017 Nov 29.

26.

Impacts of sodium-glucose co-transporter type 2 inhibitors on central blood pressure.

Takenaka T, Ohno Y, Suzuki H.

Diab Vasc Dis Res. 2018 Mar;15(2):154-157. doi: 10.1177/1479164117742317. Epub 2017 Nov 23.

PMID:
29168387
27.

Effects of vitamin K antagonist on aortic valve degeneration in non-valvular atrial fibrillation patients: Prospective 4-year observational study.

Yamamoto K, Koretsune Y, Akasaka T, Kisanuki A, Ohte N, Takenaka T, Takeuchi M, Yoshida K, Iwade K, Okuyama Y, Hirano Y, Takeda Y, Tsukamoto Y, Kinugasa Y, Nakatani S, Sakamoto T, Iwakura K, Sozu T, Masuyama T; Japanese Aortic Stenosis Study-2 (JASS-2) Investigators.

Thromb Res. 2017 Dec;160:69-75. doi: 10.1016/j.thromres.2017.10.027. Epub 2017 Nov 6.

PMID:
29121522
28.

Assessment of pleural air leakage using digital chest drainage system after surgical pulmonary resection: Comparison of visible alveolar air leakage with the digital value measured by a digital chest drainage system.

Mori R, Yamazaki K, Shoji F, Kouso H, Ushijima C, Miura N, Takenaka T, Takeo S.

PLoS One. 2017 Nov 6;12(11):e0187705. doi: 10.1371/journal.pone.0187705. eCollection 2017.

29.

Formation of the chaperonin complex studied by 2D NMR spectroscopy.

Takenaka T, Nakamura T, Yanaka S, Yagi-Utsumi M, Chandak MS, Takahashi K, Paul S, Makabe K, Arai M, Kato K, Kuwajima K.

PLoS One. 2017 Oct 23;12(10):e0187022. doi: 10.1371/journal.pone.0187022. eCollection 2017.

30.

Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study.

Shoji F, Miura N, Matsubara T, Akamine T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Toyokawa G, Takenaka T, Yamazaki K, Okamoto T, Takeo S, Maehara Y.

Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):389-394. doi: 10.1093/icvts/ivx337.

PMID:
29049803
31.

Full-Gap Superconductivity Robust against Disorder in Heavy-Fermion CeCu_{2}Si_{2}.

Takenaka T, Mizukami Y, Wilcox JA, Konczykowski M, Seiro S, Geibel C, Tokiwa Y, Kasahara Y, Putzke C, Matsuda Y, Carrington A, Shibauchi T.

Phys Rev Lett. 2017 Aug 18;119(7):077001. doi: 10.1103/PhysRevLett.119.077001. Epub 2017 Aug 18.

PMID:
28949698
32.

Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.

Sadahira T, Wada K, Araki M, Ishii A, Watanabe T, Nasu Y, Tsugawa M, Takenaka T, Nasu Y, Kumon H.

Int J Urol. 2017 Dec;24(12):842-847. doi: 10.1111/iju.13447. Epub 2017 Sep 20.

33.

Gefitinib Enhances Mitochondrial Biological Functions in NSCLCs with EGFR Mutations at a High Cell Density.

Takenaka T, Katayama M, Sugiyama A, Hagiwara M, Fujii I, Takatani-Nakase T, Kobayashi SS, Nakase I.

Anticancer Res. 2017 Sep;37(9):4779-4788.

PMID:
28870896
34.

The prognostic impact of combined pulmonary fibrosis and emphysema in patients with clinical stage IA non-small cell lung cancer.

Takenaka T, Furuya K, Yamazaki K, Miura N, Tsutsui K, Takeo S.

Surg Today. 2018 Feb;48(2):229-235. doi: 10.1007/s00595-017-1577-8. Epub 2017 Aug 18.

PMID:
28821979
35.

Synthesis of Aryl C-Glycosides via Iron-Catalyzed Cross Coupling of Halosugars: Stereoselective Anomeric Arylation of Glycosyl Radicals.

Adak L, Kawamura S, Toma G, Takenaka T, Isozaki K, Takaya H, Orita A, Li HC, Shing TKM, Nakamura M.

J Am Chem Soc. 2017 Aug 9;139(31):10693-10701. doi: 10.1021/jacs.7b03867. Epub 2017 Aug 1.

PMID:
28762276
36.

Fully gapped superconductivity with no sign change in the prototypical heavy-fermion CeCu2Si2.

Yamashita T, Takenaka T, Tokiwa Y, Wilcox JA, Mizukami Y, Terazawa D, Kasahara Y, Kittaka S, Sakakibara T, Konczykowski M, Seiro S, Jeevan HS, Geibel C, Putzke C, Onishi T, Ikeda H, Carrington A, Shibauchi T, Matsuda Y.

Sci Adv. 2017 Jun 23;3(6):e1601667. doi: 10.1126/sciadv.1601667. eCollection 2017 Jun.

37.

Fabry disease.

Yuasa T, Takenaka T, Higuchi K, Uchiyama N, Horizoe Y, Cyaen H, Mizukami N, Takasaki K, Kisanuki A, Miyata M, Ohishi M.

J Echocardiogr. 2017 Dec;15(4):151-157. doi: 10.1007/s12574-017-0340-x. Epub 2017 Jul 3. Review.

PMID:
28674962
38.

Osimertinib reactivated immune-related colitis after treatment with anti-PD1 antibody for non-small cell lung cancer.

Takenaka T, Yamazaki K, Miura N, Harada N, Takeo S.

Invest New Drugs. 2017 Dec;35(6):848-850. doi: 10.1007/s10637-017-0481-9. Epub 2017 Jun 10.

PMID:
28601918
39.

Clinical outcome of patients treated with re-irradiation for spine or pelvic bone metastasis: A multi-institutional analysis of 98 patients.

Suzuki G, Yamazaki H, Aibe N, Masui K, Kimoto T, Tatekawa K, Nakashima A, Takenaka T, Nishimura T, Sasaki N, Oh RJ, Konishi K, Okabe H, Nagasawa S, Yamada K.

Mol Clin Oncol. 2017 Jun;6(6):871-875. doi: 10.3892/mco.2017.1245. Epub 2017 May 8.

40.

Palliative Radiotherapy in the Local Management of Stage IVB Esophageal Cancer: Factors Affecting Swallowing and Survival.

Suzuki G, Yamazaki H, Aibe N, Masui K, Tatekawa K, Sasaki N, Kimoto T, Nishimura T, Nakashima A, Takenaka T, Fujiwara H, Ishikawa T, Yamada K.

Anticancer Res. 2017 Jun;37(6):3085-3092.

PMID:
28551648
41.

Sodium-glucose co-transporter type 2 inhibitors reduce evening home blood pressure in type 2 diabetes with nephropathy.

Takenaka T, Kishimoto M, Ohta M, Tomonaga O, Suzuki H.

Diab Vasc Dis Res. 2017 May;14(3):258-261. doi: 10.1177/1479164117690299. Epub 2017 Feb 1.

PMID:
28467199
42.

Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases.

Yoshida K, Yamazaki H, Kotsuma T, Akiyama H, Takenaka T, Masui K, Yoshioka Y, Uesugi Y, Shimbo T, Yoshikawa N, Yoshioka H, Arika T, Tanaka E, Narumi Y.

J Contemp Brachytherapy. 2017 Feb;9(1):66-70. doi: 10.5114/jcb.2017.65163. Epub 2017 Jan 16.

43.

Stage IV pleomorphic carcinoma of the lung without recurrence for 6 years: a case report.

Miura N, Mori R, Takenaka T, Yamazaki K, Momosaki S, Takeo S.

Surg Case Rep. 2017 Dec;3(1):36. doi: 10.1186/s40792-017-0310-6. Epub 2017 Feb 21.

45.

Development of Caco-2 cells co-expressing CYP3A4 and NADPH-cytochrome P450 reductase using a human artificial chromosome for the prediction of intestinal extraction ratio of CYP3A4 substrates.

Takenaka T, Kazuki K, Harada N, Kuze J, Chiba M, Iwao T, Matsunaga T, Abe S, Oshimura M, Kazuki Y.

Drug Metab Pharmacokinet. 2017 Feb;32(1):61-68. doi: 10.1016/j.dmpk.2016.08.004. Epub 2016 Aug 26.

PMID:
28139373
46.

A case of anticoagulant treatment-resistant Trousseau syndrome controlled by treatment of the underlying lung adenocarcinoma: Utility of monitoring D-dimer levels.

Kuwahata S, Takenaka T, Yasuda S, Sakoda T, Taniyama H, Nagata Y, Iwakawa J, Matsumoto S, Seto T, Takenoyama M, Abe S, Ohishi M.

J Cardiol Cases. 2016 Dec 24;15(2):65-69. doi: 10.1016/j.jccase.2016.10.010. eCollection 2017 Feb.

47.

Kidney resistive index relates to variations of home blood pressure in chronic kidney diseases.

Takenaka T, Ohno Y, Suzuki H.

Clin Exp Hypertens. 2016;38(8):751-756. doi: 10.1080/10641963.2016.1200062. Epub 2016 Dec 12.

PMID:
27936958
48.

Definitive Radiation Therapy for Angiosarcoma of the Face and Scalp.

Suzuki G, Yamazaki H, Takenaka H, Aibe N, Masui K, Kimoto T, Tatekawa K, Nakashima A, Takenaka T, Asai J, Komori S, Wada M, Katoh N, Yamada K.

In Vivo. 2016 11-12;30(6):921-926.

PMID:
27815481
49.

Klotho suppresses the renin-angiotensin system in adriamycin nephropathy.

Takenaka T, Inoue T, Miyazaki T, Kobori H, Nishiyama A, Ishii N, Hayashi M, Suzuki H.

Nephrol Dial Transplant. 2017 May 1;32(5):791-800. doi: 10.1093/ndt/gfw340.

50.

Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.

Kubo T, Ochi Y, Baba Y, Hirota T, Tanioka K, Yamasaki N, Yoshimitsu M, Higuchi K, Takenaka T, Nakajima K, Togawa T, Tsukimura T, Sano S, Tei C, Sakuraba H, Kitaoka H.

J Cardiol. 2017 Jan;69(1):302-307. doi: 10.1016/j.jjcc.2016.05.014. Epub 2016 Aug 21.

Supplemental Content

Loading ...
Support Center